EC conditionally approved Moderna vaccine

(ČIA) The COVID-19 vaccine from Moderna is conditionally approved by the European Commission (EC). It is the second vaccine that can be used in the European Union. The EC based its decision on the recommendation of the Committee for Medicinal Products for Human Use (CHMP), the State Institute for Drug Control informed.



Register newsletter

Get to know about Nordic Chamber, our press releases and all news, straight to your inbox.